NYMXF

NYMOX PHARMACEUTICAL CORP

CIK 0001018735 · OTC

OTCHealth CareIn Vitro & In Vivo Diagnostic Substances

$0.00

↑ 0.00 (0.00%)

as of Aug 21, 2026

End-of-day close, not real-time intraday

Overall read: NeutralOverall score · based on 2/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals; Risks: Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap

$18.91K

P/E Ratio

-0.00

EPS

-0.05

Dividend Yield

Not covered

52W Position

Beta

-0.44

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

-0.00

P/S

Not covered

EV/Revenue

Not covered

ROE

66.3%

Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 0%

$0.00$0.20

Latest Financials

2024-12-31 FY

Revenue

–

Net Income

-$4.49M

Total Assets

$654.00K

Free Cash Flow

-$2.60M

NYMXF

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

NYMXF

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news